Anteris Technologies Ltd.
Clinical trials sponsored by Anteris Technologies Ltd., explained in plain language.
-
New heart valve device shows promise for aortic stenosis patients
Disease control OngoingThis study is testing a new device called the DurAVR™ THV system for people with severe aortic stenosis, a condition where the heart's aortic valve becomes narrow and stiff. The study involves 40 participants who need a valve replacement and are eligible for a minimally invasive …
Phase: NA • Sponsor: Anteris Technologies Ltd. • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
New heart valve shows promise in early trial for aortic stenosis
Disease control OngoingThis early study tests a new device called DurAVR™ THV to replace a narrowed heart valve in people with severe aortic stenosis. The goal is to see if the procedure is safe and feasible in 15 patients aged 65 or older. The device is delivered through a leg artery, avoiding open-he…
Phase: NA • Sponsor: Anteris Technologies Ltd. • Aim: Disease control
Last updated May 26, 2026 07:23 UTC